We provide 1 form of Vorapaxar
Vorapaxar
618385-01-6
|
492.242
|
4.341
Vorapaxar inhibits platelet aggregation through the reversible antagonism of protease-activated receptor 1. It is used to reduce thrombotic cardiovascular events in patients with a history of myocardial infarction or peripheral arterial disease.
Sch 530348 | vorapaxar
Vorapaxar inhibits platelet aggregation through the reversible antagonism of protease-activated receptor 1. It is used to reduce thrombotic cardiovascular events in patients with a history of myocardial infarction or peripheral arterial disease.
Sch 530348 | vorapaxar
$41/5 mg
(EBC)
1
We provide 0 compound for Vorapaxar